Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes
Identifieur interne : 003C58 ( Main/Exploration ); précédent : 003C57; suivant : 003C59Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes
Auteurs : Alexander Wolters [Allemagne] ; Joseph Classen [Allemagne] ; Erwin Kunesch [Allemagne] ; Annette Grossmann [Allemagne] ; Reiner Benecke [Allemagne]Source :
- Movement Disorders [ 0885-3185 ] ; 2004-05.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Aged, Antiparkinson Agents (therapeutic use), Basal Ganglia Diseases (drug therapy), Basal Ganglia Diseases (pathology), Basal Ganglia Diseases (physiopathology), Corpus Callosum (pathology), Corpus Callosum (physiopathology), Diagnosis, Differential, Electromyography, Humans, Levodopa (therapeutic use), Magnetic Resonance Imaging, Magnetoencephalography (methods), Middle Aged, Motor Cortex (pathology), Motor Cortex (physiopathology), Multiple System Atrophy (drug therapy), Multiple System Atrophy (pathology), Multiple System Atrophy (physiopathology), Muscle, Skeletal (pathology), Muscle, Skeletal (physiopathology), Nerve Degeneration (drug therapy), Nerve Degeneration (pathology), Nerve Degeneration (physiopathology), Nerve Net (pathology), Nerve Net (physiopathology), Nervous system diseases, Neural Inhibition (physiology), Parkinsonian Disorders (drug therapy), Parkinsonian Disorders (pathology), Parkinsonian Disorders (physiopathology), Supranuclear Palsy, Progressive (drug therapy), Supranuclear Palsy, Progressive (pathology), Supranuclear Palsy, Progressive (physiopathology), corpus callosum, inhibition, ipsilateral silent period, magnetic resonance imaging, parkinsonian syndromes, transcranial magnetic stimulation.
- MESH :
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- drug therapy : Basal Ganglia Diseases, Multiple System Atrophy, Nerve Degeneration, Parkinsonian Disorders, Supranuclear Palsy, Progressive.
- methods : Magnetoencephalography.
- pathology : Basal Ganglia Diseases, Corpus Callosum, Motor Cortex, Multiple System Atrophy, Muscle, Skeletal, Nerve Degeneration, Nerve Net, Parkinsonian Disorders, Supranuclear Palsy, Progressive.
- physiology : Neural Inhibition.
- physiopathology : Basal Ganglia Diseases, Corpus Callosum, Motor Cortex, Multiple System Atrophy, Muscle, Skeletal, Nerve Degeneration, Nerve Net, Parkinsonian Disorders, Supranuclear Palsy, Progressive.
- Aged, Diagnosis, Differential, Electromyography, Humans, Magnetic Resonance Imaging, Middle Aged.
Abstract
Clinicopathologic evidence suggests differential involvement of cortex and corpus callosum (CC) in various disorders presenting with a parkinsonian syndrome. We tested the hypothesis of whether neurophysiologic and morphometric assessments of CC as surrogate parameters of cortical involvement could be helpful in differential diagnosis of parkinsonian disorders. The integrity of CC was assessed neurophysiologically by measuring the ipsilateral silent period (iSP) evoked by transcranial magnetic stimulation (TMS) in a total of 25 patients with idiopathic parkinsonian syndromes (IPS), corticobasal ganglionic degeneration (CBD), progressive supranuclear palsy (PSP), or multiple system atrophy (MSA). Additionally, morphometric analyses of magnetic resonance imaging (MRI) measurements of CC was carried out in all patients. iSP was abnormal in all 5 CBD and all 5 PSP patients, whereas it was intact in all 10 IPS patients and all 5 MSA patients. Among various MRI parameters of CC, testing between different groups revealed a significant difference only for measurements of the middle part of the truncus. CBD and PSP patients exhibited a significant atrophy as compared with control subjects. These data suggest impairment of callosal integrity in patients with CBD and PSP. iSP measurements may be a useful clinical neurophysiologic test in differential diagnosis of patients with parkinsonian syndromes. © 2004 Movement Disorder Society
Url:
DOI: 10.1002/mds.20064
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000572
- to stream Istex, to step Curation: 000572
- to stream Istex, to step Checkpoint: 002639
- to stream PubMed, to step Corpus: 003472
- to stream PubMed, to step Curation: 003472
- to stream PubMed, to step Checkpoint: 003411
- to stream Ncbi, to step Merge: 000E12
- to stream Ncbi, to step Curation: 000E12
- to stream Ncbi, to step Checkpoint: 000E12
- to stream Main, to step Merge: 005616
- to stream PascalFrancis, to step Corpus: 002196
- to stream PascalFrancis, to step Curation: 000B25
- to stream PascalFrancis, to step Checkpoint: 002104
- to stream Main, to step Merge: 005942
- to stream Main, to step Curation: 003C58
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes</title>
<author><name sortKey="Wolters, Alexander" sort="Wolters, Alexander" uniqKey="Wolters A" first="Alexander" last="Wolters">Alexander Wolters</name>
</author>
<author><name sortKey="Classen, Joseph" sort="Classen, Joseph" uniqKey="Classen J" first="Joseph" last="Classen">Joseph Classen</name>
</author>
<author><name sortKey="Kunesch, Erwin" sort="Kunesch, Erwin" uniqKey="Kunesch E" first="Erwin" last="Kunesch">Erwin Kunesch</name>
</author>
<author><name sortKey="Grossmann, Annette" sort="Grossmann, Annette" uniqKey="Grossmann A" first="Annette" last="Grossmann">Annette Grossmann</name>
</author>
<author><name sortKey="Benecke, Reiner" sort="Benecke, Reiner" uniqKey="Benecke R" first="Reiner" last="Benecke">Reiner Benecke</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A2E68BC3186C9231DD7BA735F035EDDF7371362D</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.20064</idno>
<idno type="url">https://api.istex.fr/document/A2E68BC3186C9231DD7BA735F035EDDF7371362D/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000572</idno>
<idno type="wicri:Area/Istex/Curation">000572</idno>
<idno type="wicri:Area/Istex/Checkpoint">002639</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Wolters A:measurements:of:transcallosally</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15133815</idno>
<idno type="wicri:Area/PubMed/Corpus">003472</idno>
<idno type="wicri:Area/PubMed/Curation">003472</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003411</idno>
<idno type="wicri:Area/Ncbi/Merge">000E12</idno>
<idno type="wicri:Area/Ncbi/Curation">000E12</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000E12</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Wolters A:measurements:of:transcallosally</idno>
<idno type="wicri:Area/Main/Merge">005616</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:04-0301533</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002196</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000B25</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002104</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Wolters A:measurements:of:transcallosally</idno>
<idno type="wicri:Area/Main/Merge">005942</idno>
<idno type="wicri:Area/Main/Curation">003C58</idno>
<idno type="wicri:Area/Main/Exploration">003C58</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes</title>
<author><name sortKey="Wolters, Alexander" sort="Wolters, Alexander" uniqKey="Wolters A" first="Alexander" last="Wolters">Alexander Wolters</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Human Cortical Physiology Laboratory, Department of Neurology, University of Rostock</wicri:regionArea>
<wicri:noRegion>University of Rostock</wicri:noRegion>
<wicri:noRegion>University of Rostock</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Classen, Joseph" sort="Classen, Joseph" uniqKey="Classen J" first="Joseph" last="Classen">Joseph Classen</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Human Cortical Physiology Laboratory, Department of Neurology, University of Rostock</wicri:regionArea>
<wicri:noRegion>University of Rostock</wicri:noRegion>
<wicri:noRegion>University of Rostock</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Human Cortical Physiology and Motor Control Laboratory, Department of Neurology, University of Würzburg</wicri:regionArea>
<wicri:noRegion>University of Würzburg</wicri:noRegion>
<wicri:noRegion>University of Würzburg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kunesch, Erwin" sort="Kunesch, Erwin" uniqKey="Kunesch E" first="Erwin" last="Kunesch">Erwin Kunesch</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Human Cortical Physiology Laboratory, Department of Neurology, University of Rostock</wicri:regionArea>
<wicri:noRegion>University of Rostock</wicri:noRegion>
<wicri:noRegion>University of Rostock</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Grossmann, Annette" sort="Grossmann, Annette" uniqKey="Grossmann A" first="Annette" last="Grossmann">Annette Grossmann</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute for Diagnostic and Interventional Radiology, University of Rostock</wicri:regionArea>
<wicri:noRegion>University of Rostock</wicri:noRegion>
<wicri:noRegion>University of Rostock</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Benecke, Reiner" sort="Benecke, Reiner" uniqKey="Benecke R" first="Reiner" last="Benecke">Reiner Benecke</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Human Cortical Physiology Laboratory, Department of Neurology, University of Rostock</wicri:regionArea>
<wicri:noRegion>University of Rostock</wicri:noRegion>
<wicri:noRegion>University of Rostock</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-05">2004-05</date>
<biblScope unit="vol">19</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="518">518</biblScope>
<biblScope unit="page" to="528">528</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">A2E68BC3186C9231DD7BA735F035EDDF7371362D</idno>
<idno type="DOI">10.1002/mds.20064</idno>
<idno type="ArticleID">MDS20064</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Basal Ganglia Diseases (drug therapy)</term>
<term>Basal Ganglia Diseases (pathology)</term>
<term>Basal Ganglia Diseases (physiopathology)</term>
<term>Corpus Callosum (pathology)</term>
<term>Corpus Callosum (physiopathology)</term>
<term>Diagnosis, Differential</term>
<term>Electromyography</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Magnetic Resonance Imaging</term>
<term>Magnetoencephalography (methods)</term>
<term>Middle Aged</term>
<term>Motor Cortex (pathology)</term>
<term>Motor Cortex (physiopathology)</term>
<term>Multiple System Atrophy (drug therapy)</term>
<term>Multiple System Atrophy (pathology)</term>
<term>Multiple System Atrophy (physiopathology)</term>
<term>Muscle, Skeletal (pathology)</term>
<term>Muscle, Skeletal (physiopathology)</term>
<term>Nerve Degeneration (drug therapy)</term>
<term>Nerve Degeneration (pathology)</term>
<term>Nerve Degeneration (physiopathology)</term>
<term>Nerve Net (pathology)</term>
<term>Nerve Net (physiopathology)</term>
<term>Nervous system diseases</term>
<term>Neural Inhibition (physiology)</term>
<term>Parkinsonian Disorders (drug therapy)</term>
<term>Parkinsonian Disorders (pathology)</term>
<term>Parkinsonian Disorders (physiopathology)</term>
<term>Supranuclear Palsy, Progressive (drug therapy)</term>
<term>Supranuclear Palsy, Progressive (pathology)</term>
<term>Supranuclear Palsy, Progressive (physiopathology)</term>
<term>corpus callosum</term>
<term>inhibition</term>
<term>ipsilateral silent period</term>
<term>magnetic resonance imaging</term>
<term>parkinsonian syndromes</term>
<term>transcranial magnetic stimulation</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Basal Ganglia Diseases</term>
<term>Multiple System Atrophy</term>
<term>Nerve Degeneration</term>
<term>Parkinsonian Disorders</term>
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Magnetoencephalography</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Basal Ganglia Diseases</term>
<term>Corpus Callosum</term>
<term>Motor Cortex</term>
<term>Multiple System Atrophy</term>
<term>Muscle, Skeletal</term>
<term>Nerve Degeneration</term>
<term>Nerve Net</term>
<term>Parkinsonian Disorders</term>
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Neural Inhibition</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Basal Ganglia Diseases</term>
<term>Corpus Callosum</term>
<term>Motor Cortex</term>
<term>Multiple System Atrophy</term>
<term>Muscle, Skeletal</term>
<term>Nerve Degeneration</term>
<term>Nerve Net</term>
<term>Parkinsonian Disorders</term>
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Diagnosis, Differential</term>
<term>Electromyography</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Clinicopathologic evidence suggests differential involvement of cortex and corpus callosum (CC) in various disorders presenting with a parkinsonian syndrome. We tested the hypothesis of whether neurophysiologic and morphometric assessments of CC as surrogate parameters of cortical involvement could be helpful in differential diagnosis of parkinsonian disorders. The integrity of CC was assessed neurophysiologically by measuring the ipsilateral silent period (iSP) evoked by transcranial magnetic stimulation (TMS) in a total of 25 patients with idiopathic parkinsonian syndromes (IPS), corticobasal ganglionic degeneration (CBD), progressive supranuclear palsy (PSP), or multiple system atrophy (MSA). Additionally, morphometric analyses of magnetic resonance imaging (MRI) measurements of CC was carried out in all patients. iSP was abnormal in all 5 CBD and all 5 PSP patients, whereas it was intact in all 10 IPS patients and all 5 MSA patients. Among various MRI parameters of CC, testing between different groups revealed a significant difference only for measurements of the middle part of the truncus. CBD and PSP patients exhibited a significant atrophy as compared with control subjects. These data suggest impairment of callosal integrity in patients with CBD and PSP. iSP measurements may be a useful clinical neurophysiologic test in differential diagnosis of patients with parkinsonian syndromes. © 2004 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
</country>
</list>
<tree><country name="Allemagne"><noRegion><name sortKey="Wolters, Alexander" sort="Wolters, Alexander" uniqKey="Wolters A" first="Alexander" last="Wolters">Alexander Wolters</name>
</noRegion>
<name sortKey="Benecke, Reiner" sort="Benecke, Reiner" uniqKey="Benecke R" first="Reiner" last="Benecke">Reiner Benecke</name>
<name sortKey="Classen, Joseph" sort="Classen, Joseph" uniqKey="Classen J" first="Joseph" last="Classen">Joseph Classen</name>
<name sortKey="Classen, Joseph" sort="Classen, Joseph" uniqKey="Classen J" first="Joseph" last="Classen">Joseph Classen</name>
<name sortKey="Grossmann, Annette" sort="Grossmann, Annette" uniqKey="Grossmann A" first="Annette" last="Grossmann">Annette Grossmann</name>
<name sortKey="Kunesch, Erwin" sort="Kunesch, Erwin" uniqKey="Kunesch E" first="Erwin" last="Kunesch">Erwin Kunesch</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003C58 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003C58 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:A2E68BC3186C9231DD7BA735F035EDDF7371362D |texte= Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes }}
This area was generated with Dilib version V0.6.23. |